Are you concerned about the formality of the Bida project?

Ordinary. Caring for Bida project is carried out in cooperation with legal medical institutions and professional medical teams, and has been approved by China Pharmaceutical Products Administration (NMPA). Therefore, from the perspective of laws and regulations, it is legal to take care of Bida project. Caring for Bida Project is a targeted biotherapy project initiated by Sanofi China and Maxim Health for patients with moderate and severe atopic dermatitis (AD). The treatment scheme of this project is to use biological agent Dupixent for treatment.